Filing Details
- Accession Number:
- 0001209191-23-016507
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 18:55:56
- Reporting Period:
- 2023-03-06
- Accepted Time:
- 2023-03-06 18:55:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662774 | Quince Therapeutics Inc. | QNCX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1606905 | Ted Monohon | C/O Quince Therapeutics, Inc. 601 Gateway Blvd., Suite 1250 South San Francisco CA 94080 | Chief Accounting Officer & Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-06 | 1,871 | $0.98 | 27,440 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022.
Billionaire Hedge Funds
